Multi-stage Friend murine erythroleukemia: Molecular insights into oncogenic cooperation

Retrovirology

Volumn 5, Issue , 2008, Pages

  Moreau Gachelin, Françoise ^a,b  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN 55; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CELL DIFFERENTIATION; DISEASE COURSE; ERYTHROBLASTOSIS; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; HUMAN; INFECTION SENSITIVITY; LEUKEMIA; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; NONHUMAN; PROTEIN FUNCTION; RETROVIRUS INFECTION; REVIEW; TRANSGENIC MOUSE; VIREMIA; ANIMAL; CELL PROLIFERATION; CELL TRANSFORMATION; MALE; MOUSE; NEWBORN; ONCOGENE; PATHOGENICITY; PATHOLOGY; SPLEEN FOCUS FORMING VIRUS; VIROLOGY;

FRIEND MURINE LEUKEMIA VIRUS; MURINAE; MUS; SPLEEN FOCUS-FORMING VIRUS;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; MALE; MICE; ONCOGENES; SPLEEN FOCUS-FORMING VIRUSES;

EID: 56849087289     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-99     Document Type: Review

References (132)

1. Kabat D Molecular biology of Friend viral erythroleukemia Curr Top Microbiol Immunol 1989, 148:1-42. 2684547
2. Chesebro B Miyazawa M Britt WJ Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection Annu Rev Immunol 1990, 8:477-499. 10.1146/annurev.iy.08.040190.002401 2188671
3. Goff SP Retrovirus restriction factors Mol Cell 2004, 16:849-859. 10.1016/j.molcel.2004.12.001 15610729
4. Miyazawa M Tsuji-Kawahara S Kanari Y Host genetic factors that control immune responses to retrovirus infections Vaccine 2008, 26:2981-2996. 10.1016/j.vaccine.2008.01.004 18255203
5. Lilly F Susceptibility to two strains of Friend leukemia virus in mice Science 1967, 155:461-462. 10.1126/science.155.3761.461 6015694
6. Pincus T Rowe WP Lilly F A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus J Exp Med 1971, 133:1234-1241. 2138931 4325133 10.1084/jem.133.6.1234
7. Jolicoeur P The Fv-1 gene of the mouse and its control of murine leukemia virus replication Curr Top Microbiol Immunol 1979, 86:67-122. 227645
8. Best S Le Tissier P Towers G Stoye JP Positional cloning of the mouse retrovirus restriction gene Fv1 Nature 1996, 382:826-829. 10.1038/ 382826a0 8752279
9. Towers G Bock M Martin S Takeuchi Y Stoye JP Danos O A conserved mechanism of retrovirus restriction in mammals Proc Natl Acad Sci USA 2000, 97:12295-12299. 17335 11027299 10.1073/pnas.200286297
10. Stremlau M Owens CM Perron MJ Kiessling M Autissier P Sodroski J The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys Nature 2004, 427:848-853. 10.1038/nature02343 14985764
11. Hatziioannou T Perez-Caballero D Yang A Cowan S Bieniasz PD Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha Proc Natl Acad Sci USA 2004, 101:10774-10779. 490010 15249685 10.1073/pnas.0402361101
12. Stevens A Bock M Ellis S LeTissier P Bishop KN Yap MW Taylor W Stoye JP Retroviral capsid determinants of Fv1 NB and NR tropism J Virol 2004, 78:9592-9598. 514981 15331691 10.1128/JVI.78.18.9592-9598.2004
13. Lassaux A Sitbon M Battini JL Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions J Virol 2005, 79:6560-6564. 1091700 15858043 10.1128/ JVI.79.10.6560-6564.2005
14. Chesebro B Wehrly K Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex Proc Natl Acad Sci USA 1979, 76:425-429. 382952 284359 10.1073/pnas.76.1.425
15. Doig D Chesebro B Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production J Exp Med 1979, 150:10-19. 2185602 286744 10.1084/ jem.150.1.10
16. Stopak K de Noronha C Yonemoto W Greene WC HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability Mol Cell 2003, 12:591-601. 10.1016/ S1097-2765(03)00353-8 14527406
17. Marin M Rose KM Kozak SL Kabat D HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat Med 2003, 9:1398-1403. 10.1038/nm946 14528301
18. Santiago ML Montano M Benitez R Messer RJ Yonemoto W Chesebro B Hasenkrug KJ Greene WC Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection Science 2008, 321:1343-1346. 10.1126/science.1161121 18772436
19. Takeda E Tsuji-Kawahara S Sakamoto M Langlois MA Neuberger MS Rada C Miyazawa M Mouse APOBEC3 restricts Friend leukemia virus infection and pathogenesis in vivo J Virol 2008, 82(22):10998-11008. 10.1128/ JVI.01311-08 18786991
20. Friend C Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia J Exp Med 1957, 105:307-318. 2136697 13416470 10.1084/jem.105.4.307
21. Tambourin PE Wendling F Jasmin C Smadja-Joffe F The physiopathology of Friend leukemia Leuk Res 1979, 3:117-129. 10.1016/0145-2126(79)90009-2 381791
22. Rauscher FJ A virus-induced disease of mice characterized by erythrocytopoiesis and lymphoid leukemia J Natl Cancer Inst 1962, 29:515-543. 14490596
23. Mirand EA Virus-induced erythropoiesis in hypertransfused-polycythemic mice Science 1967, 156:832-833. 10.1126/science.156.3776.832 4960553
24. Mirand EA Steeves RA Lange RD Grace JT Jr Virus-induced polycythemia in mice: Erythropoiesis without erythropoietin Proc Soc Exp Biol Med 1968 ,128:844-849. 5668141
25. Tambourin P Wendling F Malignant transformation and erythroid differentiation by polycythaemia-inducing Friend virus Nat New Biol 1971, 234:230-233. 10.1038/234230a0 5288817
26. Liao SK Axelrad AA Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with friend virus Int J Cancer 1975, 15:467-482. 10.1002/ijc.2910150313 1140862
27. Tambourin PE Wendling F Target cell for oncogenic action of polycythaemia-inducing Friend virus Nature 1975, 256:320-322. 10.1038/ 256320a0 1143333
28. Fredrickson T Tambourin P Wendling F Jasmin C Smajda F Target cell of the polycythemia-inducing Friend virus: Studies with myleran J Natl Cancer Inst 1975, 55:443-446. 1159825
29. Tambourin P Wendling F Moreau-Gachelin F Friend leukemia as a multiple-step disease Blood Cells 1981, 7:133-144. 7187746
30. Mager DL Mak TW Bernstein A Quantitative colony method for tumorigenic cells transformed by two distincts strains of Friend leukemia virus Proc Nat Acad Sci USA 1981, 78:1703-1707. 319201 6940184 10.1073/ pnas.78.3.1703
31. Ben-David Y Bernstein A Friend virus-induced erythroleukemia and the multistage nature of cancer Cell 1991, 66:831-834. 10.1016/ 0092-8674(91)90428-2 1889087
32. Marks PA Rifkind RA Erythroleukemic differentiation Annu Rev Biochem 1978, 47:419-448. 10.1146/annurev.bi.47.070178.002223 354501
33. Gillet N Florins A Boxus M Burteau C Nigro A Vandermeers F Balon H Bouzar AB Defoiche J Burny A Reichert M Kettmann R Willems L Mechanisms of leukemogenesis induced by bovine leukemia virus: Prospects for novel anti-retroviral therapies in human Retrovirology 2007, 4:18. 1839114 17362524 10.1186/1742-4690-4-18
34. Ruta M Kabat D Plasma membrane glycoproteins encoded by cloned Rauscher and Friend spleen focus-forming viruses J Virol 1980, 35:844-853. 288878 7420541
35. Vogt M Haggblom C Swift S Haas M Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses J Virol 1985, 55:184-192. 254914 4009793
36. Wolff L Ruscetti S Malignant transformation of erythroid cells in vivo by introduction of a nonreplicating retrovirus vector Science 1985, 228:1549-1552. 10.1126/science.2990034 2990034
37. Matsuoka M Jeang KT Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation Nat Rev Cancer 2007, 7:270-280. 10.1038/nrc2111 17384582
38. Matsuoka M Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL) Retrovirology 2005, 2:27. 1131926 15854229 10.1186/1742-4690-2-27
39. Linemeyer DL Menke JG Ruscetti SK Evans LH Scolnick EM Envelope gene sequences which encode the gp52 protein of spleen focus-forming virus are required for the induction of erythroid cell proliferation J Virol 1982, 43:223-233. 256113 6955527
40. Ruta M Bestwick R Machida C Kabat D Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus Proc Natl Acad Sci USA 1983, 80:4704-4708. 384112 6308644 10.1073/pnas.80.15.4704
41. Clark SP Mak TW Fluidity of a retrovirus genome Journal of Virology 1984, 50:759-765. 255734 6328005
42. Zon LI Moreau JF Koo JW Mathey-Prevot B D'Andrea AD The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein Mol Cell Biol 1992, 12:2949-2957. 364508 1320192
43. Li JP Hu HO Niu QT Fang C Cell surface activation of the erythropoietin receptor by friend spleen focus-forming virus gp55 J Virol 1995, 69:1714-1719. 188774 7853508
44. Wolff L Ruscetti S The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia J Virol 1988, 62:2158-2163. 253318 2835516
45. Aizawa S Suda Y Furuta Y Yagi T Takeda N Watanabe N Nagayoshi M Ikawa Y Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells EMBO J 1990, 9(7):2107-2116. 551930 2162763
46. Li JP D'Andrea AD Lodish HF Baltimore D Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor Nature 1990, 343:762-764. 10.1038/343762a0 2154701
47. Chung SW Wolff L Ruscetti SK Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth Proc Natl Acad Sci USA 1989, 86:7957-7960. 298191 2554298 10.1073/pnas.86.20.7957
48. Ruscetti SK Janesch NJ Chakraborti A Sawyer ST Hankins WD Friend Spleen-Focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line J Virol 1990, 64:1057-1062. 249217 2154592
49. Constantinescu SN Keren T Russ WP Ubarretxena-Belandia I Malka Y Kubatzky KF Engelman DM Lodish HF Henis YI The erythropoietin receptor transmembrane domain mediates complex formation with viral anemic and polycythemic gp55 proteins J Biol Chem 2003, 278:43755-43763. 10.1074/ jbc.M302974200 12930840
50. Nishigaki K Thompson D Hanson C Yugawa T Ruscetti S The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk J Virol 2001, 75:7893-7903. 115033 11483734 10.1128/ JVI.75.17.7893-7903.2001
51. Zhang J Randall MS Loyd MR Li W Schweers RL Persons DA Rehg JE Noguchi CT Ihle JN Ney PA Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia Blood 2006, 107:73-78. 1392603 16174761 10.1182/blood-2005-05-1784
52. Persons DA Paulson RF Loyd MR Herley MT Bodner SM Bernstein A Correll PH Ney PA Fv2 encodes a truncated form of the Stk receptor tyrosine kinase Nat Genet 1999, 23:159-165. 10.1038/13787 10508511
53. Rulli K Yugawa T Hanson C Thompson D Ruscetti S Nishigaki K Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation J Virol 2004, 78:4573-4581. 387688 15078939 10.1128/JVI.78.9.4573-4581.2004
54. Lilly F Fv-2: Identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice J Natl Cancer Inst 1970, 45:163-169. 5449211
55. Iwama A Okano K Sudo T Matsuda Y Suda T Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells Blood 1994, 83:3160-3169. 8193352
56. Yamamura Y Senda H Kageyama Y Matsuzaki T Noda M Ikawa Y Erythropoietin and friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells Mol Cell Biol 1998, 18:1172-1180. 108830 9488432
57. Nishigaki K Hanson C Ohashi T Spadaccini A Ruscetti S Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1 J Virol 2006, 80:5678-5685. 1472600 16731906 10.1128/ JVI.02651-05
58. Teal HE Ni S Xu J Finkelstein LD Cheng AM Paulson RF Feng GS Correll PH GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells Oncogene 2006, 25:2433-2443. 10.1038/sj.onc.1209288 16314834
59. Subramanian A Hegde S Correll PH Paulson RF Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility Leuk Res 2006, 30:1141-1149. 10.1016/ j.leukres.2006.02.006 16527351
60. Jelacic TM Thompson D Hanson C Cmarik JL Nishigaki K Ruscetti S The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation J Virol 2008, 82:419-427. 2224391 17959667 10.1128/ JVI.01349-07
61. Muszynski KW Ohashi T Hanson C Ruscetti SK Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathway J Virol 1998, 72:919-925. 124561 9444983
62. Muszynski KW Thompson D Hanson C Lyons R Spadaccini A Ruscetti SK Growth factor-independent proliferation of erythroid cells infected with friend spleen focus-forming virus is protein kinase C dependent but does not require ras-GTP [In Process Citation] J Virol 2000, 74:8444-8451. 116355 10954544 10.1128/JVI.74.18.8444-8451.2000
63. Moreau-Gachelin F Robert-Lezenes J Wendling F Tavitian A Tambourin P Integration of spleen focus-forming virus proviruses in Friend tumor cells J Virol 1985, 53:292-295. 255034 2981349
64. Moreau-Gachelin F Tavitian A Tambourin P Spi-1 is a putative oncogene in virally induced murine erythroleukemia Nature (London) 1988, 331:277-280. 10.1038/331277a0
65. Paul R Schuetze S Kozak SL Kabat D A common site for immortalizing proviral integrations in Friend erythroleukemia: Molecular cloning and characterization J Virol 1989, 63:4958-4961. 251145 2552176
66. Moreau-Gachelin F Ray D Mattei MG Tambourin P Tavitian A The putative oncogene Spi-1: Murine chromosomal localization and transcriptional activation in murine acute erythroleukemias [published erratum appears in Oncogene 1990 Jun;5(6):941] Oncogene 1989, 4:1449-1456. 2594367
67. Okuno: Y Huang G Rosenbauer F Evans EK Radomska HS Iwasaki H Akashi K Moreau-Gachelin F Li Y Zhang P Göttgens B Tenen DG Potential autoregulation of transcription factor PU.1 by an upstream regulatory element Mol Cell Biol 2005, 25:2832-2845. 1061634 15767686 10.1128/ MCB.25.7.2832-2845.2005
68. Paul R Schuetze S Kozak SL Kozak CA Kabat D The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1 J Virol 1991, 65:464-467. 240539 1985210
69. Schuetze S Paul R Gliniak BC Kabat D Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells Mol Cell Biol 1992, 12:2967-2975. 364510 1620109
70. Longmore GD Lodish HF An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: A cytokine receptor superfamily oncogene Cell 1991, 67:1089-1102. 10.1016/ 0092-8674(91)90286-8 1662116
71. Tran Quang C Wessely O Pironin M Beug H Ghysdael J Cooperation of Spi-1/ PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-depedent differenciation in primary erythroblasts and induces their kit ligand-dependent proliferation EMBO J 1997, 16:5639-5653. 1170196 9312023 10.1093/emboj/16.18.5639
72. Pereira R Raingeaud J Pironin M Ghysdael J Quang CT SPI-1 transforming properties depend upon specifically activated forms of the EPOR Oncogene 2000, 19:5106-5110. 10.1038/sj.onc.1203886 11042699
73. Mowat M Cheng A Kimura N Bernstein A Benchimol S Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus Nature 1985, 314:633-636. 10.1038/314633a0 3990796
74. Ben-David Y Prideaux VR Chow V Benchimol SaBA Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus Oncogene 1988, 3:179-185. 2842714
75. Munroe DG Peacock JW Benchimol S Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles Mol Cell Biol 1990, 10:3307-3313. 360748 1694008
76. Lavigueur A Bernstein A p53 transgenic mice: Accelerated erythroleukemia induction by Friend virus Oncogene 1991, 6:2197-2201. 1766668
77. Prasher JM Elenitoba-Johnson KS Kelley LL Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia Oncogene 2001, 20:2946-2955. 10.1038/sj.onc.1204395 11420707
78. Johnson P Chung S Benchimol S Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin Mol Cell Biol 1993, 13:1456-1463. 359456 8441390
79. Moreau-Gachelin F Wendling F Molina T Denis N Titeux M Grimber G Briand P Vainchenker W Tavitian A Spi-1/PU.1 transgenic mice develop multistep erythroleukemias Mol Cell Biol 1996, 16:2453-2463. 231234 8628313
80. Kosmider O Denis N Lacout C Vainchenker W Dubreuil P Moreau-Gachelin F Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice Cancer Cell 2005, 8:467-478. 10.1016/j.ccr.2005.11.009 16338660
81. Rimmele P Kosmider O Mayeux P Moreau-Gachelin F Guillouf C Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation Blood 2007, 109:3007-3014. 17132716
82. McKercher SR Torbett BE Anderson KL Henkel GW Vestal DJ Baribault H Klemsz M Feeney AJ Wu GE Paige CJ Maki RA Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities Embo J 1996, 15:5647-5658. 452309 8896458
83. Scott EW Fisher RC Olson MC Kehrli EW Simon MC Singh H PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors Immunity 1997, 6:437-447. 10.1016/S1074-7613(00)80287-3 9133423
84. DeKoter RP Walsh JC Singh H PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors Embo J 1998, 17:4456-4468. 1170777 9687512 10.1093/emboj/17.15.4456
85. Anderson MK Weiss AH Hernandez-Hoyos G Dionne CJ Rothenberg EV Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage Immunity 2002, 16:285-296. 10.1016/S1074-7613(02)00277-7 11869688
86. Zou GM Chen JJ Yoder MC Wu W Rowley JD Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells Proc Natl Acad Sci USA 2005, 102:13236-13241. 1201612 16141339 10.1073/pnas.0506218102
87. Iwasaki H Somoza C Shigematsu H Duprez EA Iwasaki-Arai J Mizuno S Arinobu Y Geary K Zhang P Dayaram T Fenyus ML Elf S Chan S Kastner P Huettner CS Murray R Tenen DG Akashi K Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation Blood 2005, 106:1590-1600. 1895212 15914556 10.1182/ blood-2005-03-0860
88. Dakic A Metcalf D Di Rago L Mifsud S Wu L Nutt SL PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis J Exp Med 2005, 201:1487-1502. 2213186 15867096 10.1084/ jem.20050075
89. Klemsz MJ McKercher SR Celada A Van Beveren C Maki RA The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene Cell 1990, 61:113-124. 10.1016/0092-8674(90)90219-5 2180582
90. DeKoter RP Singh H Regulation of B lymphocyte and macrophage development by graded expression of PU.1 Science 2000, 288:1439-1441. 10.1126/ science.288.5470.1439 10827957
91. Back J Dierich A Bronn C Kastner P Chan S PU.1 determines the self-renewal capacity of erythroid progenitor cells Blood 2004, 103:3615-3623. 10.1182/blood-2003-11-4089 14739214
92. Nutt SL Metcalf D D'Amico A Polli M Wu L Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors J Exp Med 2005, 201:221-231. 2212785 15657291 10.1084/jem.20041535
93. Tsai SF Martin DI Zon LI D'Andrea AD Wong GG Orkin SH Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells Nature 1989, 339:446-451. 10.1038/339446a0 2725678
94. Evans T Felsenfeld G The erythroid-specific transcription factor Eryf1: a new finger protein Cell 1989, 58:877-885. 10.1016/0092-8674(89)90940-9 2776214
95. Ferreira R Ohneda K Yamamoto M Philipsen S GATA1 function, a paradigm for transcription factors in hematopoiesis Mol Cell Biol 2005, 25:1215-1227. 548021 15684376 10.1128/MCB.25.4.1215-1227.2005
96. Pevny L Simon MC Robertson E Klein WH Tsai SF D'Agati V Orkin SH Costantini F Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 Nature 1991, 349:257-260. 10.1038/349257a0 1987478
97. Weiss MJ Orkin SH Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis Proc Natl Acad Sci USA 1995, 92:9623-9627. 40854 7568185 10.1073/pnas.92.21.9623
98. Rekhtman N Radparvar F Evans T Skoultchi AI Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: Functional antagonism in erythroid cells Genes Dev 1999, 13:1398-1411. 316770 10364157 10.1101/gad.13.11.1398
99. Zhang P Behre G Pan J Iwama A Wara-Aswapati N Radomska HS Auron PE Tenen DG Sun Z Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1 Proc Natl Acad Sci USA 1999, 96:8705-8710. 17580 10411939 10.1073/pnas.96.15.8705
100. Nerlov C Querfurth E Kulessa H Graf T GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription Blood 2000, 95:2543-2551. 10753833
101. Stopka T Amanatullah DF Papetti M Skoultchi AI PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure Embo J 2005, 24:3712-3723. 1276718 16222338 10.1038/ sj.emboj.7600834
102. Choe KS Radparvar F Matushansky I Rekhtman N Han X Skoultchi AI Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1 Cancer Res 2003, 63:6363-6369. 14559825
103. Starck J Doubeikovski A Sarrazin S Gonnet C Rao G Skoultchi A Godet J Dusanter-Fourt I Morle F Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines Mol Cell Biol 1999, 19:121-135. 83871 9858537
104. Ben-David Y Giddens EB Letwin K Bernstein A Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1 Genes Dev 1991, 5:908-918. 10.1101/gad.5.6.908 2044959
105. Tsui HW Siminovitch KA de Souza L Tsui FW Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene Nat Genet 1993, 4:124-129. 10.1038/ng0693-124 8348149
106. Wlodarski P Zhang Q Liu X Kasprzycka M Marzec M Wasik MA PU.1 activates transcription of SHP-1 gene in hematopoietic cells J Biol Chem 2007, 282:6316-6323. 10.1074/jbc.M607526200 17218319
107. Barnache S Wendling F Lacombe C Denis N Titeux M Vainchenker W Moreau-Gachelin F Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation Oncogene 1998, 16:2989-2995. 10.1038/sj.onc.1202095 9662331
108. Scolan EL Wendling F Barnache S Denis N Tulliez M Vainchenker W Moreau-Gachelin F Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts Oncogene 2001, 20:5484-5492. 10.1038/sj.onc.1204708 11571646
109. Lennartsson J Jelacic T Linnekin D Shivakrupa R Normal and oncogenic forms of the receptor tyrosine kinase kit Stem Cells 2005, 23:16-43. 10.1634/stemcells.2004-0117 15625120
110. Munugalavadla V Kapur R Role of c-Kit and erythropoietin receptor in erythropoiesis Crit Rev Oncol Hematol 2005, 54:63-75. 10.1016/ j.critrevonc.2004.11.005 15780908
111. Rottapel R Reedijk M Williams DE Lyman SD Anderson DM Pawson T Bernstein A The Steel/W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor Mol Cell Biol 1991, 11:3043-3051. 360141 1710023
112. Reith AD Ellis C Lyman SD Anderson DM Williams DE Bernstein A Pawson T Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase Embo J 1991, 10:2451-2459. 452940 1714377
113. Serve H Yee NS Stella G Sepp-Lorenzino L Tan JC Besmer P Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells Embo J 1995, 14:473-483. 398105 7532131
114. Timokhina I Kissel H Stella G Besmer P Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Rac1 and JNK activation in mast cell proliferation Embo J 1998, 17:6250-6262. 1170951 9799234 10.1093/emboj/17.21.6250
115. Wandzioch E Edling CE Palmer RH Carlsson L Hallberg B Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines Blood 2004, 104:51-57. 10.1182/ blood-2003-07-2554 14996702
116. Longley BJ Tyrrell L Lu SZ Ma YS Langley K Ding TG Duffy T Jacobs P Tang LH Modlin I Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm Nat Genet 1996, 12:312-314. 10.1038/ng0396-312 8589724
117. Pignon JM Giraudier S Duquesnoy P Jouault H Imbert M Vainchenker W Vernant JP Tulliez M A new c-kit mutation in a case of aggressive mast cell disease Br J Haematol 1997, 96:374-376. 10.1046/ j.1365-2141.1997.d01-2042.x 9029028
118. Gari M Goodeve A Wilson G Winship P Langabeer S Linch D Vandenberghe E Peake I Reilly J c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia Br J Haematol 1999, 105:894-900. 10.1046/j.1365-2141.1999.01449.x 10554798
119. Beghini A Peterlongo P Ripamonti CB Larizza L Cairoli R Morra E Mecucci C C-kit mutations in core binding factor leukemias Blood 2000, 95:726-727. 10660321
120. Wang YY Zhou GB Yin T Chen B Shi JY Liang WX Jin XL You JH Yang G Shen ZX Chen J Xiong SM Chen GQ Xu F Liu YW Chen Z Chen SJ AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec Proc Natl Acad Sci U S A 2005, 102(4):1104-1109. 545849 15650049 10.1073/pnas.0408831102
121. Barnache S Mayeux P Payrastre B Moreau-Gachelin F Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts Blood 2001, 98:2372-2381. 10.1182/blood.V98.8.2372 11588033
122. Gilliland DG Griffin JD The roles of FLT3 in hematopoiesis and leukemia Blood 2002, 100:1532-1542. 10.1182/blood-2002-02-0492 12176867
123. Speck NA Gilliland DG Core-binding factors in haematopoiesis and leukaemia Nat Rev Cancer 2002, 2:502-513. 10.1038/nrc840 12094236
124. Tenen DG Disruption of differentiation in human cancer: AML shows the way Nat Rev Cancer 2003, 3:89-101. 10.1038/nrc989 12563308
125. Reilly JT Receptor tyrosine kinases in normal and malignant haematopoiesis Blood Rev 2003, 17:241-248. 10.1016/S0268-960X(03)00024-9 14556779
126. Reilly JT Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis? Br J Haematol 2005, 128:18-34. 10.1111/j.1365-2141.2004.05236.x 15606546
127. Rosenbauer F Koschmieder S Steidl U Tenen DG Effect of transcription-factor concentrations on leukemic stem cells Blood 2005, 106:1519-1524. 1895222 15914558 10.1182/blood-2005-02-0717
128. Scolnik MP Palacios MF Acevedo SH Castuma MV Larripa IB Palumbo A Moiraghi EB Sasot AM Huberman AB Promyelocytic blast crisis of chronic myelogenous leukaemia with translocations (9;22) and (15;17) Leuk Lymphoma 1998, 31:231-236. 9720733
129. Melnick A Licht JD Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 1999, 93:3167-3215. 10233871
130. Yamamoto Y Kiyoi H Nakano Y Suzuki R Kodera Y Miyawaki S Asou N Kuriyama K Yagasaki F Shimazaki C Akiyama H Saito K Nishimura M Motoji T Shinagawa K Takeshita A Saito H Ueda R Ohno R Naoe T Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies Blood 2001, 97:2434-2439. 10.1182/blood.V97.8.2434 11290608
131. Kottaridis PD Gale RE Frew ME Harrison G Langabeer SE Belton AA Walker H Wheatley K Bowen DT Burnett AK Goldstone AH Linch DC The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Blood 2001, 98:1752-1759. 10.1182/blood.V98.6.1752 11535508
132. Gilliland DG Hematologic malignancies Curr Opin Hematol 2001, 8:189-191. 10.1097/00062752-200107000-00001 11561153